Bachem Holding (Suzhou): difference between revisions
Diff·revision 21 → 22·07:14, 8 Jul 2025
Difference between revision 21 and revision 22 of Bachem Holding (Suzhou). 5 lines changed; the page grew by 271 bytes.
| Revision 21 — 19:14, 21 Jun 2025 PurityClaimPia (talk) add the standing talk-page note link to the banner 11,853 bytes +265 | Revision 22 — 07:14, 8 Jul 2025 StubSorterBot (talk) bot: mark outbound storefront link nofollow 12,124 bytes +271 | ||
|---|---|---|---|
| 98 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 98 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 99 | 99 | ||
| + | 100 | == Further reading == | |
| + | 101 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 102 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 103 | ||
| 100 | == See also == | 104 | == See also == |
| 101 | * [[Certificate of analysis]] | 105 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 105 | * [[Research use only]] | 109 | * [[Research use only]] |
| 106 | * [[Peptide supply chain]] | 110 | * [[Peptide supply chain]] |
| + | 111 | * [[Blind sampling]] | |
| 107 | 112 | ||
| 108 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} | 113 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} |